mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |